Synapse - Works

Results (936)

Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial

Journal Article

Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
JAMA Oncology (2016)

Fulltext@MSK | Save

Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma

Meeting Abstract

Lowery, M. A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; more...
European Journal of Cancer (2016)

Fulltext@MSK | Save

A phase I study of the MDM2 inhibitor AMG 232 in patients with advanced p53 wild type (p53WT) solid tumors or multiple myeloma

Meeting Abstract

Langenberg, M. H.; Gluck, L.; Weger, V.; Frank, R.; Eskens, F.; Blay, J. Y.; Soria, J. C.; Chawla, S.; Gounder, M.; Wagner, A.; more...
European Journal of Cancer (2016)

Fulltext@MSK | Save

Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers

Meeting Abstract

Janku, F.; Murthy, R.; Wang-Gillam, A.; Shepard, D.; Helgason, T.; Henry, T.; Rudin, C.; Huang, S.; Sakamuri, D.; Solomon, S.; more...
European Journal of Cancer (2016)

Fulltext@MSK | Save

Manipulating the immune system with checkpoint inhibitors for patients with metastatic sarcoma

Journal Article

D'Angelo, S. P.
American Society of Clinical Oncology Educational Book (2016)

Fulltext@MSK | Save

Évaluation de l’efficacité de Doxorubicine ± Olaratumab dans les STM

Meeting Abstract

Blay, J. Y.; Tap, W.; Jones, R.; Chmielowski, B.; Elias, A.; Adkins, D.; Van Tine, B.; Agulnik, M.; Cooney, M.; Livingston, M.; more...
Bulletin du Cancer (2016)

Fulltext@MSK | Save

A phase II, multi-center study of the EZH2 inhibitor, tazemetostat, in adult subjects with INI1-negative tumors including renal medullary carcinoma (RMC), or relapsed/refractory synovial sarcoma

Meeting Abstract

Tannir, N. M.; Pressey, J.; Roche, M.; Rodstrom, J.; Blakemore, S.; Clawson, A.; Daigle, S.; Gounder, M.
BJU International (2016)

Fulltext@MSK | Save

Squamous cell carcinoma associated with chronic graft versus host disease-like/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab

Journal Article

Owosho, A. A.; Randazzo, J.; Rosen, E. B.; Estilo, C. L.; Huryn, J. M.; Chi, P.; Yom, S. K.
Oral Oncology (2016)

Fulltext@MSK | Save

Detection of ALK alternative transcription initiation and MET exon 14 skipping using nanoString digital nCounter technology in a clinical setting

Meeting Abstract

Borsu, L.; Mullaney, K.; Benayed, R.; Chi, P.; Busam, K.; Paik, P.; Drilon, A.; Ladanyi, M.
Journal of Molecular Diagnostics (2016)

Fulltext@MSK | Save

Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma

Journal Article

Dickson, M. A.; Mahoney, M. R.; Tap, W. D.; D'Angelo, S. P.; Keohan, M. L.; Van Tine, B. A.; Agulnik, M.; Horvath, L. E.; Nair, J. S.; Schwartz, G. K.
Annals of Oncology (2016)

Fulltext@MSK | Save